跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 80,220 条关于
“Opko Health”
全部
80,220
临床试验
64,748
药物
318
机构
1,568
资讯
13,586
7个月前
Opko Health and Entera Bio Expand Partnership to Develop First Oral Long-Acting PTH Therapy for Hypoparathyroidism
去年
Labcorp to Acquire BioReference Health's Oncology Testing Assets in $225 Million Deal
去年
Labcorp Completes $225 Million Acquisition of BioReference Health's Oncology Testing Assets
29天前
OPKO Health Secures $125 Million Non-Dilutive Financing Against Mazdutide Royalties
去年
OPKO Health and Entera Bio Advance First-in-Class Oral Dual GLP-1/Glucagon Tablet for Obesity Treatment
10个月前
ModeX Therapeutics and Regeneron Partner on $1 Billion Multispecific Antibody Collaboration
10个月前
ModeX Therapeutics Initiates First-in-Class Trispecific Antibody Trial for Advanced Cancers
去年
OPKO Health and Entera Bio Collaborate to Develop First Oral GLP-1/Glucagon Dual Agonist for Obesity Treatment
5个月前
ModeX Therapeutics Initiates Phase 1 Trial of Novel Tetravalent COVID-19 Prevention Antibody MDX2301
去年
Entera Bio and OPKO Health Announce Positive PK/PD Results for Oral Oxyntomodulin for Obesity and Metabolic Disorders
第 1 页,共 1359 页
上一页
下一页